CNO Financial (COS) AI Stock Analysis

CNO Financial

(Frankfurt:COS)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Sustained Distribution GrowthRepeated sales expansion alongside rising agent counts indicates durable distribution momentum rather than a single product-driven result. A growing productive agent base can widen customer reach, support recurring policy and annuity inflows, and improve operating leverage as fixed infrastructure serves more business.

Negative Factors

Elevated LeverageLeverage remains elevated for an insurer whose credibility and resilience depend heavily on balance-sheet strength. Higher debt relative to equity can reduce financial flexibility, increase sensitivity to adverse operating experience, and constrain the capital available for growth, dividends, or unexpected obligations.

CNO Financial (COS) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 5.34B
Dividend Yield: 1.20%
Average Volume (3M): 39
Price to Earnings (P/E): 12.9
Beta (1Y): 0.32
Revenue Growth: -3.03%
EPS Growth: 44.62%
Country: Germany
Employees: 3,300
Sector: Financial
Sector Strength: 68
Industry: Insurance - Life

CNO Financial Business Overview & Revenue Model

Company Description

Headquartered in Carmel, Indiana, and established in 1979, CNO Financial Group, Inc. operates across the United States, developing, marketing, and administering a broad spectrum of insurance and annuity products primarily for middle-income and senior...

CNO Financial Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:2.48%|Next Earnings Date:Feb 08, 2027

Earnings Call SentimentPositive

The call was strongly positive. CNO reported substantial earnings growth, consecutive periods of sales and agent-count growth, improving expense leverage, strong investment income, robust capital levels, and raised full-year earnings guidance. The company also highlighted strong Medicare Supplement, Worksite and asset accumulation momentum. Offsetting issues included declines in reported Life NAP, unfavorable Medicare Supplement morbidity, Medicare Advantage market disruption, nonrecurring investment income outperformance, and capital consumption from investments, but management characterized demand and the overall operating outlook as resilient.

Positive Updates

Operating Earnings Delivered Strong Growth

Third-quarter operating earnings per diluted share were $1.90, up 47% year over year, while operating earnings per diluted share excluding significant items were $1.42, up 48%. Year-to-date operating earnings per diluted share were up 43%, or 45% excluding significant items.

Negative Updates

Reported Life and Health NAP Declined

Total Life and Health NAP was down year over year against a strong prior-year comparison. Reported Life NAP declined 9% for the quarter, although the company said the prior year included $13 million from a third-party pilot program that was discontinued earlier this year; excluding that production, Life NAP increased 20%.

Company Guidance

For 2026, CNO raised operating earnings per share guidance to a range of between $5.05 to $5.15, representing a 9% increase at the midpoint from prior guidance, with an expense ratio of 18.6% to 18.8%, an operating effective tax rate of approximately 20.5%, full year fee income of approximately $25 million, and free cash flow of between $220 million and $240 million; there is no change to the target RBC ratio, minimum holdco, holding company liquidity or leverage ranges, and 2026 operating return on equity is clearly on track to exceed the 12% target previously established for year-end 2027. The company expects roughly $70 million of TechMod cash spend for the full year and a comparable amount in 2027, expects to establish new long-term targets in February of next year, and said the current expense ratio is sustainable with some room for improvement going forward.

CNO Financial Risk Analysis

CNO Financial disclosed 32 risk factors in its most recent earnings report. CNO Financial reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

CNO Financial Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

DE:COS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PRI	76Outperform	$8.65B	11.27	32.55%	1.65%	8.23%	23.45%
GL	69Neutral	$12.23B	10.45	19.46%	0.79%	5.62%	8.87%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
LNC	64Neutral	$7.85B	3.42	21.99%	4.39%	12.32%	97.86%
FG	58Neutral	$2.77B	7.04	8.86%	4.73%	13.68%	16.86%
BHF	50Neutral	$2.53B	3.45	13.17%	―	2.62%	33.55%

* Financial Sector Average

Performance Comparison

DE:COS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:COS	CNO Financial Group	49.60	15.53	45.60%
LNC	Lincoln National	41.01	2.23	5.74%
PRI	Primerica	281.09	24.04	9.35%
GL	Globe Life Inc.	159.08	29.50	22.76%
BHF	Brighthouse Financial	43.92	-9.66	-18.02%
FG	F&G Annuities & Life Inc	21.13	-6.85	-24.49%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

CNO Financial AI Stock Analysis